About
One World Cannabis discovers, develops, and commercializes cannabis-based therapeutic products and treatments. One World Cannabis intends to investigate specific cannabis strains, combinations of the cannabinoids THC and CBD, and optimal dosages. The companys first clinical trials will explore potential treatments for fibromyalgia, psoriasis, basal cell carcinoma, post-traumatic stress disorder, and seizures. The second set of clinical trials will focus on the development of cannabis medicines for Crohns disease, Parkinsons disease, Tourettes syndrome, migraines, chronic pain, Alzheimers disease, pediatric epilepsy, prostate cancer, and diabetes. One World Cannabis is a wholly owned Israeli subsidiary of OWC Pharmaceutical Research Corp.
Funding history · 1 round · $2.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the operational status of One World Cannabis?
- One World Cannabis is currently inactive and ceased to operate in January 2022.
- When was One World Cannabis founded?
- One World Cannabis was founded in January 2008.
- What was the total amount of funding raised by One World Cannabis?
- One World Cannabis raised a total of $2,000,000 in an undisclosed round in December 2014. For full financing history, please refer to startupim.
- When did One World Cannabis conduct its IPO?
- One World Cannabis conducted an IPO in March 2009, trading on the OTC exchange under the ticker OWCP.
- What was a significant distribution agreement for OWC Pharmaceutical Research Corp. in 2020?
- In September 2020, OWC Pharmaceutical Research Corp. announced a new distribution agreement with Can It Industries, Florida US.
- With which medical institution did OWC Pharmaceutical Research Corp. collaborate for a safety study in 2019?
- In March 2019, OWC Pharmaceutical Research Corp. collaborated with Sourasky Medical Center in Tel Aviv for a safety study on its cannabis-based tablets.
- When was Dr. Oron Yacoby Zeevi appointed as Chief Scientific Officer for OWC Pharmaceutical Research Corp.?
- Dr. Oron Yacoby Zeevi was appointed as Chief Scientific Officer for OWC Pharmaceutical Research Corp. in March 2018.
- What was the focus of One World Cannabis's initial clinical trials?
- One World Cannabis's first clinical trials were intended to explore potential treatments for fibromyalgia, psoriasis, basal cell carcinoma, post-traumatic stress disorder, and seizures.